Topiramate USP
Item No.
696125
Description
Your patients' health is our top priority. Learn more about how Quality is at the Center of Everything We Do.
Specifications
| Pack Size | 100 G |
| Shipment type | |
| Type/DEA Schedule | API |
| Quality class | USP |
| CAS-Number | 97240-79-4 |
| NDC | 62991-3127-01 |
| Risk and Safety | HAZARD: Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation. Suspected of damaging fertility or the unborn child. Suspected of causing cancer. Causes damage to organs through prolonged or repeated exposure. PRECAUTION: Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe dust/fume/gas/mist/vapors/spray. Wash thoroughly after handling. Do not eat, drink or smoke when using this product. Use only outdoors or in a well-ventilated area. Wear protective gloves/protective clothing/eye protection/face protection. If on skin: Wash with plenty of water. IF INHALED: Remove person to fresh air and keep comfortable for breathing. If in eyes: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. IF exposed or concerned: Get medical advice/attention. Call a poison center/doctor if you feel unwell. Specific treatment (see on this label). Get medical advice/attention if you feel unwell. Take off contaminated clothing and wash it before reuse. If skin irritation occurs: Get medical advice/attention. If eye irritation persists: Get medical advice/attention. Store in a well-ventilated place. Keep container tightly closed. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations. |
| Storage Condition | Preserve in tight, light resistant containers and store at a temperature not exceeding 25°C under nitrogen. |
| Spec | Great care must be exercised in handling topiramate because it is a suspected teratogen. |
| Use | For Manufacturing, Processing, Repackaging and Pharmaceutical Compounding. |
| NIOSH | Group 3 |
| FedLaw | Caution: RX ONLY |
| Danger Sign 1 |  |
| Danger Sign 2 | GHS08 |
| Danger Sign 3 | |
| Danger Sign 4 | |
| Danger Sign 5 |
Documents
